[{"id":"892f8bfe-f3a3-41f7-abce-f53c3d9ea4f5","acronym":"","url":"https://clinicaltrials.gov/study/NCT04982926","created_at":"2021-07-29T14:53:20.869Z","updated_at":"2024-07-02T16:35:22.257Z","phase":"Phase 1","brief_title":"A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer","source_id_and_acronym":"NCT04982926","lead_sponsor":"Taiho Oncology, Inc.","biomarkers":" EGFR • HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["EGFR • HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TAS2940"],"overall_status":"Recruiting","enrollment":" Enrollment 42","initiation":"Initiation: 09/16/2021","start_date":" 09/16/2021","primary_txt":" Primary completion: 05/01/2025","primary_completion_date":" 05/01/2025","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2024-01-25"}]